跳至主要内容
临床试验/NCT04066517
NCT04066517招募中不适用

STereotactic RadioAblation by Multimodal Imaging for VT (STRA-MI-VT)

Centro Cardiologico Monzino4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
4
主要终点
SBRT efficacy based on reduction of VT episodes during 12 month follow-up

研究概览

简要总结

Study of multimodal-imaging guided stereotactic body radiotherapy (SBRT) for ventricular tachycardia (VT) ablation.

详细描述

STRA-MI-VT study is a spontaneous, open-label, not randomized, prospective clinical trial.

The objective of the study is to evaluate the safety and efficacy of SBRT in strictly selected patients with refractory VT.

Multimodal cardiac imaging combined with electroanatomic mapping to provide a specific patient's tailored SBRT treatment plan choosing amang different linear accelerators.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

No masking in this study.

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICD/S-ICD recipients with refractory VT
  • Not eligible for conventional catheter ablation or -in alternative- that have undergone failing conventional catheter ablation attempts, refusing surgery for the treatment of the arrhythmia.
  • LVEF ≥ 20%.
  • Age ≥ 50 years.
  • Signed an IRB approved written informed consent document.

排除标准

  • Previous radiotherapy with cardiac involvement.
  • Pregnancy or breastfeeding.
  • Active myocardial ischemia.
  • Acute revascularation in the past 120 days.
  • Acute hemodynamic instability (cardiogenic shock/NYHA IV).
  • Serious disease with presumed life expectancy less than 12 months.
  • Any condition that is deemed a contraindication in the judgment of the investigators.

结局指标

主要结局

SBRT efficacy based on reduction of VT episodes during 12 month follow-up

时间窗: 12 months

There will be 6 week blanking period after therapy to allow for ablation effect

SBRT safety during 12 month follow-up

时间窗: 12 months

Serious adverse events will be defined using CTCAE v4.0 criteria.

次要结局

  • Total mortality(12 months)
  • Health related quality of life(12 months)
  • Cardiac functional changes(12 months)

研究者

发起方
Centro Cardiologico Monzino
申办方类型
Other
责任方
Principal Investigator
主要研究者

Corrado Carbucicchio

Head of Ventricular Intensive Care Unit

Centro Cardiologico Monzino

研究点 (4)

Loading locations...

相似试验